Download - Dr Deagle's H1N1 Report
-
7/31/2019 Dr Deagle's H1N1 Report
1/61
LAB ORIGINS OFA H1N1 MEXICAN
FRANKENFLU &TOXIC EUGENIC
MANDATORY
VACCINESDR BILL DEAGLE MD
DABFP AAEM A4M
NUTRIMEDICAL.COMLABVIRUS.COM BLOG
-
7/31/2019 Dr Deagle's H1N1 Report
2/61
RESCUE FROM PANDEMIC FLU& TOXIC VACCINES
WHO UN EUGENICSPOPULATION CONTROL
TIMETHEHIntroduction
Strategy
Challenges Forward3
2
1 ORIGINS OF PANDEMIC FLU
-
7/31/2019 Dr Deagle's H1N1 Report
3/61
A H1N1
LABFLU2009
H5N1
AVIANFLU1997
1918
H1N1SWINE
FLU
VACCINE
MISHAP
&
EUGENIC
BIOWEAPONS
-
7/31/2019 Dr Deagle's H1N1 Report
4/61
LAB ORIGINS OF A H1N1SWINE FLU
-
7/31/2019 Dr Deagle's H1N1 Report
5/61
1917 TYPHUS VACCINE SWINE FLU ORIGINS AS
RECOMBINANT SWINE AND HUMAN FLU DR HENRY L. NIMAN DR BILL DEAGLE
MD AUGUST 2006 REVIEW OF PROOFOF WSN33 OLDEST HUMAN AND IOWA
PIG FLU RECOMBINANT ORIGINS OF1918 FLU
TYPHUS VACCINE PASSED THROUGH
PIGS ON VACCINE FACILITY FT.LUPTON, KANSAS, USA
SPONTANEOUS RECOMBINANTINFECTED TROOPS HEADED ON AIR
TROOP TRANSPORTS TO SPAIN, WWI
-
7/31/2019 Dr Deagle's H1N1 Report
6/61
RESURRECTION OF THE 1918PANDEMIC SWINE FLU
1951 US TEAM FAIL TO GROW VIRUS IN LABCULTURE FROM ALASKA EXUMED VICTUMS OF
1918 SWINE FLU 1997 MARCH 16TH BASEL, SWITZERLAND -
HUMAN LIFE INTERNATIONAL PRIVATE BOARDMEETING 3 PROJECTS
LATE 90s - DR TAUBENBERG PhD CDC HEADSTEAM TO USE PROMIS ORACLE 8iSUPERCOMPUTER SOFTWARE TO RESURRECTGENE FRAGMENTS 1918 FLU Ref: Dr True OttPhD ND
-
7/31/2019 Dr Deagle's H1N1 Report
7/61
WHO UN GLOBAL EUGENICS
POPULATION PROJECTS:
1- PLAMID ANTI-HCG PLACENTALABORTION VACCINATIONAFRICA,
PHILLIPINES AND SOUTH AMERICA
2 SPECIAL VIRUS PROJECTMYCOPLASMA HOSTED RNA
RETROVIRUS IMMUNE FAILURE ANDCANCERAIDS VIRUS
3 RESURRECTED PANDEMIC FLU1918AVIAN SWINE BINARY
WEAPON
-
7/31/2019 Dr Deagle's H1N1 Report
8/61
NOVARTIS PHARMA ORACLE 8i
VIRAL RESURRECTION FOUR NATIONS USA CDC, NIAID, USAMRID
CANADA NATL MICROBIOLOGY, WINNIPEG, BRITAIN,ISRAEL BIOWEAPONS NEGEV
SUCCESSFUL RESURRECTION OF H1N1 NOVEL VIRUSWSN33 HUMAN AND
IOWA PIG FLU RECOMBINANT WITH NOVARTISORACLE 8i SUPERCOMPUTER AND BIOENGINE GENESEQUENCER
2007 PATENT FOR NOVEL H1N1 VIRUS APPLICATION
SOURCEs: 1997 HLI Zurich, Switzerland WHOUN, and 2009 ResearchDr True Ott PhD ND &Don Nicoloff Novartis DayCart Daylight Oracle 8i
Supercomputer Predictive Software
-
7/31/2019 Dr Deagle's H1N1 Report
9/61
BIOENGINEERED SUPERCOMPUTER
ORACLE 8i LABVIRUS PLAQUE FLU Novartis patent specifically details that the viral
pathogen which the patented vaccine is designedto protect against is a
Reverse Engineered Designer Virus that couldonly have been created in the labs of
Ft. Detrick utilizing ORACLE 8i equippedcomputers.
EXACTLY what Michael Riconosciuto testifiedabout years earlier concerning the BiologicalWarfare capabilities of ORACLE 8i software.
Source: Dr True Ott PhD ND
-
7/31/2019 Dr Deagle's H1N1 Report
10/61
VACCINE-INDUCED DISEASE
EPIDEMIC OUTBREAKS (V.I.D.E.O.s)
The Engineering of Pandemics
By A. True Ott, PhD, ND
AMA, JOHN D ROCKEFELLER 1921
PROOF ADVERTISERS PROTECTIVE BUREAUKANSAS SMALLPOX VACCINE DISEASE EPIDEMIC
VACCINES CONTAIN LIVE VIRUSES, ONLY WEAKENEDOR ATTENUATED THAT CAN CAUSE DISEASE
V.I.D.E.O.s IS AN EFFICIENT TOOL OF SOCIALMANIPULATION OF LARGE GROUPS OF POPULATION
AND GENERATING BILLIONS IN PROFIT
ALL THE PANDEMICS OF THE 20THAND EARLY 21ST
CENTURY INCLUDING AIDS, LYME, AND SWINE FLU
-
7/31/2019 Dr Deagle's H1N1 Report
11/61
RESURRECTING PANDEMIC FLU OF 1918
1997 RELEASE OF UPGRADED AVIAN H5N1 FLU :
NEW NS1 FOUR AMINO ACID DELETION BYPASSINGIL4 IMMUNE ALARM,
OLD 1918 PB2 AND OTHER LETHAL GENETIC SNPs
FROM 1918 WNS33 HUMAN / IOWA 1930 PIG FLURECOMBINANT VIA TYPHUS PASS-THROUGHCOMINGLING OF VIRUSES IN PIGS
H GENE 6 BASIC AMINO ACIDS CHANGE FROM 1971U OF EDIBURGH, SCOTLAND H5N1 FLU WHO
REFERENCE LAB SEQUENCES ONLY 3 OF 5 AMINO ACIDS IN RECEPTOR BINDING
DOMAIN TO ATTACH TO HUMAN CELLS ON H GENE
A H1N1 MEXICAN LABVIRUS HAS ALL FIVERECEPTOR BINDING H GENES, 2.3 TIMES FASTER
TRIMER OF PB1, PB2 AND PA GENETIC REPLICATION
-
7/31/2019 Dr Deagle's H1N1 Report
12/61
CDC A H1N1 MEXICAL FLU
ELECTRON MICROSCOPY
-
7/31/2019 Dr Deagle's H1N1 Report
13/61
A H1N1 TRIPLE TRIPLE
LABVIRUS RECOMBINANT
-
7/31/2019 Dr Deagle's H1N1 Report
14/61
A H1N1 SWINE MEDICANN FRANKENVIRUS
FOUR SOURCES & THREE CONTINENTS 6 TO 8 % NO DATABASE GENE MATCHES
-
7/31/2019 Dr Deagle's H1N1 Report
15/61
DR ADRIAN GIBBS PhD VIRAL GENETICS
LAB RECOMBINANT ORIGINS
-
7/31/2019 Dr Deagle's H1N1 Report
16/61
LAB ORIGINS OF A H1N1
PANDEMIC SWINE FLU
-
7/31/2019 Dr Deagle's H1N1 Report
17/61
Resurrected Pandemic Influenza Viruses
Terrence M. Tumpey and Jessica A.Belser
Influenza Division, National Center forImmunization and Respiratory Diseases,Centers
for Disease Control and Prevention,
Atlanta, Georgia 30333; email:[email protected]
-
7/31/2019 Dr Deagle's H1N1 Report
18/61
PLASMID ENGINEERED FLU VIRUSES
-
7/31/2019 Dr Deagle's H1N1 Report
19/61
Resurrected Pandemic Influenza Viruses
Abstract Influenza viruses continue to pose a major global public health problem.
There is a need to better understand the pathogenicity and transmission
of pandemic influenza viruses so that we may develop improved methods
for their prevention and control. Reconstruction of the 1918 virus
and studies elucidating the exceptional virulence and transmissibility of
the virus are providing exciting new insights into this devastating pandemic
strain. The primary approach has been to reconstruct and analyze
recombinant viruses, in which genes of the 1918 virus are replaced with
genes of contemporary influenza viruses of lesser virulence. This review
highlights the current status of the field and discusses the molecular determinants of the 1918 pandemic virus that may have contributed to
its virulence and spread. Identifying the exact genes responsible for the
high virulence of the 1918 virus will be an important step toward understanding
virulent influenza strains and will allow the world to better
prepare for and respond to future influenza pandemics.
-
7/31/2019 Dr Deagle's H1N1 Report
20/61
Resurrected Pandemic Influenza Viruses
The high replication efficiency of the reconstructed
1918 virus observed in mouse and human airway cells appears tobe the result of molecular determinants in the HA, NA, and PB1
virus genes. The role of PB1 may reflect the polymerase activity of the PB1
protein itself or the proapoptotic viral protein, PB1-F2, generatedby an alternative reading frame in the PB1 gene segment.
While the role of the PB1 gene is likely to be crucial component of1918 virus virulence, PB2 appears to contribute to the
transmissibility of this virus by allowing increased replication atlower temperatures in the airways of mammals.
Although a number of selected 1918 virus genes were critical, it ismost certainly the coordinated expression ofall 1918 virus genesthat confers the unique highly virulent, transmissible phenotypeobserved with this pandemic virus.
-
7/31/2019 Dr Deagle's H1N1 Report
21/61
Resurrected Pandemic Influenza Viruses 1. Sequence analysis of the 1918H1N1viral
genome and the plasmid-based reverse geneticssystem has allowed researchers an
unprecedented opportunity to study thecomposition of the virus responsible for theinfluenza pandemic of 1918.
2. Among the eight 1918 gene segments studied,the HA, NA, and PB1 genes contributedsignificantly to the efficient replication andenhanced virulence of the pandemic strain.
3. The surface glycoproteins and PB2 segmentsof the 1918 virus are sufficient to confer virus
transmissibility of an avian H1N1 virus.
-
7/31/2019 Dr Deagle's H1N1 Report
22/61
Top Cited Literature by Dr Tumpey & Belser
Demonstrated that viruses possessing the1918 NS gene segment were attenuated in mice.
7. Basler CF, Reid AH, Dybing JK, Janczewski TA,Fanning TG, et al. 2001. Sequence of the 1918 pandemic
influenza virus nonstructural gene (NS) segment andcharacterization of recombinant viruses bearing the1918 NS genes. Proc. Natl. Acad. Sci. USA 98:274651
Identified that glycan topology, as well as glycancomposition, affects receptor binding of influenza
viruses. 11. Chandrasekaran A, Srinivasan A, Raman R,
Viswanathan K, Raguram S, et al. 2008. Glycan topologydetermines human adaptation of avian H5N1 virushemagglutinin. Nat. Biotechnol. 26:10713
-
7/31/2019 Dr Deagle's H1N1 Report
23/61
Top Cited Literature by Dr Tumpey & Belser
Documents the discovery of PB1-F2 protein, generatedby an alternative reading frame of the influenza PB1gene.
13. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et
al. 2001. A novel influenza A virus mitochondrial proteinthat induces cell death. Nat. Med. 7:130612
Describes the plasmid-based reverse genetics system
used to rescue influenza A viruses in cell culture.
21. Fodor E, Devenish L, Engelhardt OG, Palese P,
Brownlee GG, Garcia-Sastre A. 1999. Rescue ofinfluenza A virus from recombinant DNA. J. Virol.73:967982
-
7/31/2019 Dr Deagle's H1N1 Report
24/61
Top Cited Literature by Dr Tumpey & Belser
Testing of singlegene H1N1 reassortant 1918 virusesidentified crucial role of HA, NA, and PB1 segments invirus replication and virulence.
74. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng
H, et al. 2008. Single gene reassortants identify a criticalrole for PB1, HA, and NA in the high virulence of the1918 pandemic influenza virus. Proc. Natl. Acad. Sci.USA 105:306469
Reported the first documented influenza outbreak caused by a
wholly avian virus directly transmitting to humans frominfected poultry and causing death.
94. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al.1998. Characterization of an avian Influenza A (H5N1) virusisolated from a child with a fatal respiratory illness. Science279:39396
-
7/31/2019 Dr Deagle's H1N1 Report
25/61
Top Cited Literature by Dr Tumpey & Belser
Describes the initial isolation and phylogenetic analysisof multiple genes of 1918 virus sequences, which areconsistent with an H1N1 influenza A virus belonging tothe subgroup of strains that infects humans.
98. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE,Fanning TG. 1997. Initial genetic characterization of the1918 Spanish influenza virus. Science275:179396
First report characterizing the fully reconstructed 1918virus, including mammalian challenge data.
103. Tumpey TM, Basler CF, Aguilar PV, Zeng H,Solorzano A, et al. 2005. Characterization of thereconstructed 1918 Spanish influenza pandemic virus.
Science310:7780
-
7/31/2019 Dr Deagle's H1N1 Report
26/61
REVERSE ENGINEERED FLU
PLAGUES & THERAPEUTICS
-
7/31/2019 Dr Deagle's H1N1 Report
27/61
WORLD DEPOPULATION IS TOP
NSA AGENDA - CLUB OF ROME National Security Council's Ad Hoc Group onPopulation Policy.
Policy-planning group is in the U.S.State
Department's Office of Population Affairs,established in 1975 by Henry Kissinger, StateDepartment's Office of Population Affairs(OPA).
This group drafted the Carter administration'sGlobal 2000 document
National Security Study Memorandum 200"(NSSM 200)... "food as a weapon Kissinger
-
7/31/2019 Dr Deagle's H1N1 Report
28/61
WORLD DEPOPULATION IS TOP
NSA AGENDA - CLUB OF ROME The sphere of Kissinger In 1975, OPAwas brought under a reorganized StateDepartment Bureau of Oceans,
International Environmental, and ScientificAffairs-- a body created byHenry Kissinger.
The agency was assigned to carry out thedirectives of the NSC Ad Hoc Group.
-
7/31/2019 Dr Deagle's H1N1 Report
29/61
WORLD DEPOPULATION IS TOPNSA AGENDA - CLUB OF ROME
Kissinger initiated both groups after discussionwith leaders of the Club of Rome during the 1974population conferences in Bucharest and Rome.
The Club of Rome, controlled by Europe's blacknobility, is the primary promotion agency for thegenocidal reduction of world population levels.
The Ad Hoc Group was given "high priority" by
the Carter administration, through the interventionof National Security Adviser Zbigniew Brzezinskiand Secretaries of State Cyrus Vance andEdmund Muskie.
-
7/31/2019 Dr Deagle's H1N1 Report
30/61
WORLD DEPOPULATION IS TOP
NSA AGENDA - CLUB OF ROME Bureau of Oceans, InternationalEnvironmental, and Scientific Affairs hasconsistently blocked industrialization
policies in the Third World, Denying developing nations access to
nuclear energy technology--the policies
that would enable countries to sustain agrowing population.
-
7/31/2019 Dr Deagle's H1N1 Report
31/61
NEW LAWS AND PLANS FOR THEPERFECT PANDEMIC FLU STORM
Public Readiness and Emergency PreparednessAct 0f 2006.
US government is using laws designed for dealingwith a very deadly pandemic, or bioterrorism, tobring about a mass vaccination program for swineflu
This law removes liability from the manufacturer,medical practitioners who use the product, andfrom "government program planners" who decidedon using the law
-
7/31/2019 Dr Deagle's H1N1 Report
32/61
NATIONAL GOVT TO WHO UN
PANDEMIC FLU CONTROL MODEL STATE EMERGENCY HEALTH POWERS ACTS NATIONAL SECURITY PRESIDENTIAL DIRECTIVE/NSPD 51
and
HOMELAND SECURITY PRESIDENTIAL DIRECTIVE/HSPD-20
National Emergency Act SEIZURE OF TRANSPORT,PROPERTY, FOOD, ETC.
PANDEMIC LEVEL 6 TRANSFER ALL CONTROL TO WHO UNCONTROL 2005 S.P.P. SECURITY AND SECURITY &PROSPERITY PARTNERSHIP AND
2006 SIGNED194 NATIONS NEW UN WHO TREATY OFPANDEMIC CONTROL BY WHO AND UN AUTHORITIES
HHS HEALTH AND HUMAN SERVICES OBAMA ADMIN HHSSEC. SEBELIUS MANDATORY VOLUNTARY WITHCONSEQUEN CES NATIONAL VACCINE FALL 2009 WINTER
2010
-
7/31/2019 Dr Deagle's H1N1 Report
33/61
NEW LAWS AND PLANS FOR THE
PERFECT PANDEMIC FLU STORM
Tamiflu and Relenza protection fromliability Tamiflu Hallucinogenic Angel
Dust
Novel Vaccine Adjuvants MF 59 Novartis,and AS03 Glaxo Smith Kline Squalene
oil based super adjuvants and Tween +gp120 glycoprotein amplifier ( adjuvantswill be used in vaccines to stretch thesupply)
-
7/31/2019 Dr Deagle's H1N1 Report
34/61
NEW LAWS AND PLANS FOR THE
PERFECT PANDEMIC FLU STORM
Novartis began testing in humans in July, 2009
Sanofi-Aventis and Glaxo Smith Kline in August
,2009 Attenuated viruses WITHOUT adjuvant toxoins
HHS is lobbying FDA to approve dangerousprotein antigen sparing adjuvants and vaccine
grown on non-egg cell lines from aborted baby celllines with various viral oncogenic , mycoplasma,and bacterial contaminants
-
7/31/2019 Dr Deagle's H1N1 Report
35/61
NEW LAWS AND PLANS FOR THEPERFECT PANDEMIC FLU STORM
Congressional Research Service, on April 27, 2009, theFood and Drug Administration issued fourEmergency Use
Authorizations (enacted in Section 564 of the Federal Food,Drug, and Cosmetic Act, amended by the Project BioShield
Act of 2004) in response to requests from the CDC to makeavailable certain drugs (Tamiflu and Relenza), diagnostictests and respiratory protection devices.
Use of unapproved (unlicensed) medical treatments andtests, or use of approved treatments for unapproved uses
Pregnant mothers Class 3 Dangers (4x riskof H1N1 Flu Complications, Young adults
and children Unethical Testing Protocol
http://biotech.law.lsu.edu/blaw/H1N1-2009/R40560_20090521.pdfhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://biotech.law.lsu.edu/blaw/H1N1-2009/R40560_20090521.pdf -
7/31/2019 Dr Deagle's H1N1 Report
36/61
NEW LAWS AND PLANS FOR THEPERFECT PANDEMIC FLU STORM
Vaccines containing MF59 andASO3 have nothad Emergency Use Authorizations issued for
them--yet. USA government has purchased $698 million
dollars' worth of these adjuvants in August, 2009
US and WHO officials have announced intentions
to use these viral antigen stretching adjuvants tosupply adequate vaccine for Fall 2009 Winter2010
http://www.bloomberg.com/apps/news?pid=20601085&sid=aeKFOHbajydMhttp://www.bloomberg.com/apps/news?pid=20601085&sid=aeKFOHbajydM -
7/31/2019 Dr Deagle's H1N1 Report
37/61
THE PANDEMIC FLU MANIPULATEDPERFECT STORM
New Bioterrorism laws (passed with theexpectation of use for much more dangerous
epidemics than the current swine flu) Allow use of untested products AND
Give manufacturers an incentive to avoidcomprehensive testing (to avoid being found guilty
of willful misconduct) have Combined with the political imperative to provide
citizens with vaccines in a hurry,
Yielding a potential Perfect Storm.
SOURCE: Dr Meryl Nass MD MPH Int Med
-
7/31/2019 Dr Deagle's H1N1 Report
38/61
1976 Swine Flu Vaccine Program 45 million people were vaccinated with aninadequately tested vaccine
Government gave the vaccine
manufacturers immunity from liability
Created an alternative compensationprogram
Five thousand people sought benefits forvaccine injuries
475 Guillain-Barre Syndrome
Over 30 to 50 died directly from vaccine
-
7/31/2019 Dr Deagle's H1N1 Report
39/61
TESTING AND SURVEILLANCE
OF A H1N1 FLU VACCINES
Absence ofPrelicensure Clinical Trial Data
Mandatory Vaccination of All of US population will
cause death, spontaneous miscarriage,autoimmune disease and progressive neurologicaldisorders and more
Road blocks and school lockdowns of Voluntary
with Consequences vaccination with refusal metby forced quarantine with RFID steel bracelets
Legal Injunctions in all states, countries, and
Danger of violent resistance is very probable
-
7/31/2019 Dr Deagle's H1N1 Report
40/61
Guillaine-Barre Paralysis Risk of A
H1N1 Flu Vaccination The British Neurological Surveillance Unit(BNSU), part of the British Association of
Neurologists, has been asked to monitor closely
any cases of GBS as the vaccine is rolled out. One senior neurologist said last night: I would not
have the swine flu jab because of the GBS risk.
There are concerns that there could be a repeat of
what became known as the 1976 debacle in theUS, where a swine flu vaccine killed 25 peoplemore than the virus itself.
-
7/31/2019 Dr Deagle's H1N1 Report
41/61
Guillaine-Barre Paralysis Risk of A
H1N1 Flu Vaccination Australian National Medical Malpractice Insurancewill not insure doctors against suits forcomplications such as GBS, death, or othercomplications
CMPA Canadian Medical Protective Associationwill likewise be pressured into not protectingdoctors and nurses who participate in the NationalMandatory Vaccination Program
US Private Medical Malpractice Insurers can alsobe pressured into non-coverage for liability ofdeath, paralysis and autoimmune diseases andother complications e.g. autism, miscarriage etc.
-
7/31/2019 Dr Deagle's H1N1 Report
42/61
DEADLY 'SIX' CONSEQUENCES OF FORCED
MEXICAN A H1N1 VACCINATION PROGRAMS:
1] DEPRESSION OF IMMUNE PROTECTION AGAINSTANY INFECTION AND MORE AND MORE SERIOUSHUMAN CASES OF A H1N1 WITH HIGHER CASE
FATALITIES
2] ACUTE OR CHRONIC ADJUVANT TOXIN INDUCED
NEUROLOGICAL AND AUTOIMMUNE DISEASES ORACUTE SYSTEMIC COLLAPSE AND DEATH !-- CNS
DAMAGE, BEHAVIORAL DISORDERS, MOODDISORDERS, DEMENTIA, NEUROPATHY AND CNSINDUCED DEATH !
3] STEALTH PATHOGENS IN HOT BATCHES E.G.MYCOPLASMA, VIRUSES, FUNGI AND ACUTE ORCHRONIC ILLNESS ... AUTOIMMUNE AND CANCER
-
7/31/2019 Dr Deagle's H1N1 Report
43/61
DEADLY 'SIX' CONSEQUENCES OF FORCED
MEXICAN A H1N1 VACCINATION PROGRAMS: 4] RNA AND DNA PLASMA ANTIGENIC AMPLIFICATION
IN NEW TEST VACCINES CAN SWITCH ON GENESCAUSING SERIOUS IMMEDIATE HEALTH DANGERS,AUTOIMMUNE DISEASES AND CANCER INDUCTION
5] FASTER VIRAL GENETIC JUMPS TO MOREPATHOGENIC SUBSTRAINS UNDER DRUG AND
GENETICALLY ATTENTUATED FULL OR PARTIALVIRAL GENOME IN NEW TEST VACCINES...
6] NAIS TRACKING BRACELETS OR INJECTED RFIDTRACKING CHIPS AS PART OF VERIFICATION OF
IDENTITY WITH BIOMETRIC CENTRAL DATABASES TOVERIFY SAFE LICENSED TRAVEL IN THE USA ANDCOUNTRIES WORLDWIDE !-- PART OF WHO UN
WORLD PANDEMIC CONTROL MATRIXX...!!
-
7/31/2019 Dr Deagle's H1N1 Report
44/61
NO H1N1 PANDEMIC 6 JUSTIFIED UNLESS
VACCINES UPGRADE PATHOGENICITY 1. The feared "2nd wave" of mutated "novel H1N1/H3N2/H5N1RECOMBINANT PANDEMIC VIRUS" has not appeared!
2. The "flu season" in the Southern Hemisphere is winding down.
3. Studies concluded by the CDC have CLEARLY SHOWN that this"lab-created" virus has average to low transmission issues
4. Yet, despite all of these facts, the WHO has not lowered the "Level6" alert down to what is a much more appropriate Level 3 or 4. Why isthiis? Simply because it is only at "Level 6" that the WHO has controlover the highly profitable MASS VACCINATION CAMPAIGN andforcing cumpulsory vaccines in the 194 treaty nations.
Given these facts, it should be obvious that the "Pandemic" will nothappen, unless and until ATTENUTATED, LIVE VIRUSES aresystematically spread throughout the world via the VACCINENEEDLES, or MED-IMMUNE NASAL SPRAYS to young children.
Sept 1st 2009 NutriMedical Report Show, Dr True Ott PhD ND
-
7/31/2019 Dr Deagle's H1N1 Report
45/61
NOVARTIS SPLIT VIRUS TH1
ADJUVANT TECHNOLOGY PATENT
-
7/31/2019 Dr Deagle's H1N1 Report
46/61
NOVARTIS SPLIT VIRUS TH1
ADJUVANT TECHNOLOGY PATENT Novartis applied for just such a patent on Nov. 4,2005, and the
U.S. Patent Office accepted this application and
granted US 20090047353A1 for a Split Influenza Vaccine withAdjuvants on
February 19, 2009.
Patents protecting the proprietary flu vaccine must
be applied for and secured before the pandemicvirus is released in order to minimize the
competition and maximize the profit potentials.
-
7/31/2019 Dr Deagle's H1N1 Report
47/61
PANDEMRIX BIRD FLU VACCINE Europe GlaxoSmithKline's (GSK)PANDEMRIX vaccine.
This EMEA Document is very, very
revealing.
The vaccine consists of: ActiveSubstance: Pandemic influenza vaccine
(H5N1) (split virion, inactivated,adjuvanted) A/VietNam/1194/2004 NIBRG-14.
Clearly, this is BIRD FLU vaccine
-
7/31/2019 Dr Deagle's H1N1 Report
48/61
Pandemrix European H5N1 Spit
Virion Pandemic Vaccine !? Injecting millions of people withPANDREMIX "adjuvanted" H5N1 Bird Fluviruses could indeed create the 'Perfect
Storm' A H1N1 recombination with plasmids in
Europes Pandemrix H5N1 Split Virionwould produce new viral index cladebranches with much higher case fatalities,and rapid human to human spread
Second wave A H1N1 lethal pandemic
wave may arise by this process
-
7/31/2019 Dr Deagle's H1N1 Report
49/61
NOVARTIS 2005 PATENT FOR
H1N1 NOVEL FLU VACCINE Novartis Nov. 6, 2005 provisional patentapplication. On page 2, paragraph 32 ofthe patent publication we read, quote: The
influenza virus [that the invention vaccineis designed to protect against] may be areassortant strain, and may have beenobtained by
Reverse genetics techniques allowinfluenza viruses with desired genomesegments to be prepared in vitro using
plasmids
-
7/31/2019 Dr Deagle's H1N1 Report
50/61
NOVARTIS 2005 PATENT FOR
H1N1 NOVEL FLU VACCINE African green monkey kidney cells will beused for the viral growth substrate i.e.the carrier medium. (Page 3, paragraph
0037) oil-in-water squalene-based adjuvants
will also be included (page 8 0098)recombinant and novel split vaccine,
include fragments of attenuated viruses(i.e. live pathogens) in the vaccinemedium. Source: Dr True Ott PhD ND
-
7/31/2019 Dr Deagle's H1N1 Report
51/61
OPERATION BIOSHIELDREVERSE VIRAL ENGINEERING
CREATE FUTURE PATHOGENS ANDBIOWEAPONS TO INVENTCOUNTERMEASURES
DayCart latest version ofProMis Oracle 8ipredictive software to plan
Bioengineered Future Pathogens &Bioweapons
Develop Vaccines and Pharmaceuticals toblock pathogens
Invent the problem and profit from the
solution
-
7/31/2019 Dr Deagle's H1N1 Report
52/61
INTERNATIONAL SWINE FLU CONFERENCEWashington, D.C., AUGUST 19TH TO 20TH 2009
Top Five Reasons to Attend the Summit Gain a broad birds eye view of the global swine
flu situation.
Get the freshest updates from hard-to-reach
country experts. Learn how your company / organization can
prepare for a pandemic.
Establish contacts with key local, federal and
international agencies involved in the fight againstswine flu.
Draw on first hand best practices from topcompanies to create solid business continuity
plans.
-
7/31/2019 Dr Deagle's H1N1 Report
53/61
JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES
Injunctions are orders of a court of competentjurisdiction commanding an individual,business entity, or government agency to door stop doing something.
Injunctions invoke what is called the equitablepowers of the court and, as such, thoseseeking an injunction must come to court withclean hands.
The party bringing such an action is called thepetitioner (not plaintiff). The party againstwhom the action is brought is called the
respondent (not defendant).
-
7/31/2019 Dr Deagle's H1N1 Report
54/61
JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES
Injunctions are commenced by filing a petitionwith a court of competent jurisdiction (couldbe state or federal), effective service of asummons 1 and copy of the petition on the
respondent(s) by an authorized process server2
The elements that must be (1) alleged in the
petition and subsequently (2) proven by thegreater weight of admissible evidence throughthe use of discovery are: , and payment ofrequired court fees.
-
7/31/2019 Dr Deagle's H1N1 Report
55/61
LEGAL VACCINEINJUNCTIONFIVE ELEMENTS
Threatened Harmto the Petitioner
Outweighs PublicInterest
Threatened Harm
to thePetitioner OutweighsHarm to Respondent
Imminent Likelihoodof Irreparable Harm
Unavailability Ofany AdequateRemedy at Law
Substantial Likelihoodof Success
Based on theAllegations
YOU WIN !!
-
7/31/2019 Dr Deagle's H1N1 Report
56/61
JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES
1. Existence of an imminent likelihood of irreparableharm if the injunction is not issued,
2. Unavailability of any adequate remedy at law (i.e., an
award of money damages after the harm has occurredwill not restore the petitioner?s threatened loss,
3. The threatened harm to the petitioner outweighs anysubstantial harm to the respondent,
4. Granting the injunction will not contravene asubstantial public interest, and
5. Petitioner has a substantial likelihood of successbased on the allegations, i.e., the facts alleged are likely
to be proven and are not merely speculative.
-
7/31/2019 Dr Deagle's H1N1 Report
57/61
JurisDictionary Legal Militia Start or Join aChapter in Your Town, City, State or Country
Go to www.NutriMedical.com orwww.CLAYandIRON.com and Click onProducts by Company Down toJurisDictionary and Online or theJurisDictionary Legal Militia EducationalLibrary
OR Phone 866-Law-EASY and Talk to DrFred Graves J.D. or his staffThey are one of
our great sponsorsSay to them that youwere sent to join the Legal Militia by Dr BillDeagle MD & The NutriMedical Report andCLAYandIRON SHOW
http://www.nutrimedical.com/http://www.clayandiron.com/http://www.clayandiron.com/http://www.nutrimedical.com/ -
7/31/2019 Dr Deagle's H1N1 Report
58/61
JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES
Note: In the aforementionedessential elements that must be
(1) alleged and (2) proven by thegreater weight of admissibleevidence, each word has aparticular technical meaning thatwill be used by the court to readthe petition.
-
7/31/2019 Dr Deagle's H1N1 Report
59/61
JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES
Note also: You need only allege those ultimate factsthat, if proven, establish all the five elements. Fail toallege sufficient facts to establish all five, and yourpetition will be dismissed for failure to state a claim on
which the court can grant relief (in some courts called acause of action). Allege too many facts, and you weakenyour case by muddying the waters beyond what is
necessary.
Note this, too: You must be able to prove all the factsyou allege, so you will surely shoot yourself in the footif you allege innuendo, assumptions, wild accusations,
etc. Stick to those facts that, if proven, will suffice toestablish all five elements.
Thats how you win!
-
7/31/2019 Dr Deagle's H1N1 Report
60/61
1 2 3 4
Due Process Is the KING of ALL RIGHTS
-
7/31/2019 Dr Deagle's H1N1 Report
61/61
www.NutriMedical.com
www.CLAYandIRON.com
www.LabVirus.com BLOG
http://www.nutrimedical.com/http://www.clayandiron.com/http://www.labvirus.com/http://www.labvirus.com/http://www.clayandiron.com/http://www.nutrimedical.com/